More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

Several local companies are developing technologies that they hope could replace a painful poke with something that feels more like having Velcro against your skin for a few minutes.

Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out advertisement of prescription of injectable weight-loss drugs without ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...

An arson suspect was arrested after barricading himself in a Sacramento County home that caught fire during a standoff Friday ...

Kansas voters will get the chance to approve or deny a constitutional change that would cap property tax assessments in the ...

FDA approves suzetrigine for short-term pain relief Offers opioid-level pain relief without addiction risks First new painkiller mechanism approved in 20+ years ...